WaferGen Bio-systems, Inc.
WGBS
WGBS was delisted on the 28th of February, 2017.
0 hedge funds and large institutions have $0 invested in WaferGen Bio-systems, Inc. in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 8 closing their positions.
19.21% less ownership
Funds ownership: 19.21% → 0% (-19%)
100% less funds holding
Funds holding: 9 → 0 (-9)
100% less capital invested
Capital invested by funds: $3.59M → $0 (-$3.59M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 8
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.77M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.58M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$104K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$103K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$31K |
WGBS Hedge Fund Activity: Q1 2017 in Review
0 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in WaferGen Bio-systems, Inc. (WGBS) for Q1 2017, worth a combined $0 — down 100% from $3.59M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of WGBS and 0 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Sabby Management, exiting entirely with an estimated $1.77M sold.
- 0 institutional investors held WaferGen Bio-systems, Inc. (WGBS) as of Q1 2017, down from 9 in Q4 2016.
- Funds reported $0 of WaferGen Bio-systems, Inc. stock for Q1 2017, down 100% quarter-over-quarter.
- 0 funds opened new WaferGen Bio-systems, Inc. positions in Q1 2017 and 8 closed out, a net change of -8 holders.
- The largest WaferGen Bio-systems, Inc. seller in Q1 2017 was Sabby Management, an estimated $1.77M sold.
Based on aggregated 13F filings for Q1 2017.